Jeroo Sinor is a Program Strategy Leader at Gilead Sciences, where they currently shape and advance the Trodelvy GU strategy. With a rich background in market research and strategic planning, they previously held roles at notable companies such as Roche, Genentech, and Biogen Idec, leading initiatives in Immunology, Neuroscience, and Oncology. Jeroo completed a post-doctoral fellowship in Neuroscience at Caltech and holds a Ph.D. in Neurobiology and Anatomy from the University of Pittsburgh School of Medicine. Their expertise includes driving results and managing cross-functional teams to enhance product strategies in various therapeutic areas.
This person is not in any teams
This person is not in any offices